FDA
Lidotral 5 Percent and Hydrocortisone 1 Percent with Peptides and Arnica
Indications
The product is used for the anti-inflammatory and anesthetic relief of redness, pain, itching, and discoloration due to inflammation and skin burns. For the relief of redness, pain, itching, discoloration, inflammation and mild skin burns associated with radiation. For use after radiation treatment, cosmetic procedures, sun exposure, and for inflammatory skin conditions.
Contraindications
Product should not be used in patients with a history of sensitivity to any of its ingredients or adverse reactions to lidocaine or amide anesthetics, which usually do not cross-react with “caine” ester type anesthetics. If excessive irritation and significant worsening occur, discontinue use and seek the advice of your physician. Product and topical lidocaine should be used cautiously in those with impaired liver function, as well as the very ill or very elderly and those with significant liver disease.
Product should be used with caution in patients receiving antiarrhythmic drugs of Class I since the adverse effects are additive and generally synergistic. Product is contraindicated for tuberculous or fungal lesions or skin vaccinia, varicella and acute herpes simplex. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Warnings and precautions
CONCERNS RELATED TO ADVERSE EFFECTS: Methemoglobinemia: Has been reported with local anesthetics; clinically significant methemoglobinemia requires immediate treatment along with discontinuation of the anesthetic and other oxidizing agents. Onset may be immediate or delayed (hours) after anesthetic exposure. Patients with G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, exposure to oxidizing agents or their metabolites, or infants <6 months of age are more susceptible and should be closely monitored for signs and symptoms of methemoglobinemia (including pale, gray, or blue-colored skin (cyanosis), headache, rapid pulse, shortness of breath, lightheadedness, fatigue).
WARNINGS: For external use only. Not for ophthalmic use. Stop use and ask a doctor if condition worsens or symptoms last more than 7 days or clear up and occur again within a few days. Do not apply to wounds or damaged skin. Do not use in large quantities, particularly over raw surfaces or blistered areas. If swallowed, get medical help or contact a Poison Control Center right away. Keep out of reach of children. Topical formulations of lidocaine may be absorbed to a greater extent through mucous membranes and abraded, fissured or irritated skin than through intact skin.
At a glance
- Brand name
- Lidotral 5 Percent and Hydrocortisone 1 Percent with Peptides and Arnica
- Active substance
- lidocaine hcl 5 % , hydrocortisone acetate 1%
- Application
- LABEL-Lidotral 5 Percent and Hydrocortisone 1 Percent with Peptides and Arnica
- NDC
- 59088-319-07



